Brand Name: SGONEK
Price: $5 -$8/Gram
Place of Origin: Shaanxi, China
Certification: ISO FDA SG COA MSDS
Grade: Food Grade Pharmaceutical Grade
Payment Terms: T/T, Western Union, MoneyGram
| Product Name: | Ledipasvir | Cas No.: | 1256388-51-8 |
| Molecular Formula: | / | Purity: | 99%min |
| Brand Name: | SGONEK | Certification: | ISO FDA SG COA MSDS |
| Product Name | Ledipasvir |
| CAS No. | 1256388-51-8 |
| Purity | 99% |
| Appearance | Off-white to White Powder |
| Molecular Formula | C49H54F2N8O6 |
| EINECS No. | / |
|
Description: Ledipasvir (formerly GS-5885) is a drug for the treatment of hepatitis C. The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG interferon or ribavirin. |
|
|
Item |
Specification |
|
Appearance |
Off-White Powder |
|
Water |
0.27% |
|
Acetone Content |
5.5-6.9% |
|
Related Compounds Impurity A: NMT0.20% Any Other Impurity: NMT0.20% Total Impurities:NMT1.00% |
0.14% 0% 0.14% |
|
Loss On Drying |
Not More Than 1.0% |
|
Residue On Ignition |
Not More Than 0.1% |
|
Purity By HPLC |
99.86% |
Ledipasvir (formerly GS-5885) is an experimental drug for the treatment of hepatitis C being developed by Gilead Sciences.
1. It is currently in Phase III clinical trials.
2. It is being studied in combination with other direct-acting antiviral agents that interfere with HCV replication.
